1. Home
  2. SUPN vs PRDO Comparison

SUPN vs PRDO Comparison

Compare SUPN & PRDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUPN
  • PRDO
  • Stock Information
  • Founded
  • SUPN 2005
  • PRDO 1994
  • Country
  • SUPN United States
  • PRDO United States
  • Employees
  • SUPN N/A
  • PRDO N/A
  • Industry
  • SUPN Biotechnology: Pharmaceutical Preparations
  • PRDO Other Consumer Services
  • Sector
  • SUPN Health Care
  • PRDO Real Estate
  • Exchange
  • SUPN Nasdaq
  • PRDO Nasdaq
  • Market Cap
  • SUPN 2.6B
  • PRDO 2.3B
  • IPO Year
  • SUPN 2012
  • PRDO N/A
  • Fundamental
  • Price
  • SUPN $46.02
  • PRDO $30.13
  • Analyst Decision
  • SUPN Strong Buy
  • PRDO Buy
  • Analyst Count
  • SUPN 4
  • PRDO 1
  • Target Price
  • SUPN $63.25
  • PRDO $42.00
  • AVG Volume (30 Days)
  • SUPN 1.0M
  • PRDO 590.3K
  • Earning Date
  • SUPN 11-04-2025
  • PRDO 11-04-2025
  • Dividend Yield
  • SUPN N/A
  • PRDO 1.99%
  • EPS Growth
  • SUPN N/A
  • PRDO 17.26
  • EPS
  • SUPN N/A
  • PRDO 2.33
  • Revenue
  • SUPN $681,539,000.00
  • PRDO $810,888,000.00
  • Revenue This Year
  • SUPN $8.29
  • PRDO $25.27
  • Revenue Next Year
  • SUPN $22.72
  • PRDO $4.01
  • P/E Ratio
  • SUPN N/A
  • PRDO $12.94
  • Revenue Growth
  • SUPN 4.54
  • PRDO 24.23
  • 52 Week Low
  • SUPN $29.16
  • PRDO $23.87
  • 52 Week High
  • SUPN $57.65
  • PRDO $38.03
  • Technical
  • Relative Strength Index (RSI)
  • SUPN 37.29
  • PRDO 31.45
  • Support Level
  • SUPN $43.11
  • PRDO $29.31
  • Resistance Level
  • SUPN $57.34
  • PRDO $33.69
  • Average True Range (ATR)
  • SUPN 2.50
  • PRDO 1.50
  • MACD
  • SUPN -0.98
  • PRDO -0.71
  • Stochastic Oscillator
  • SUPN 19.60
  • PRDO 12.62

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About PRDO Perdoceo Education Corporation

Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the company's revenue comes from the Colorado Technical University segment.

Share on Social Networks: